Research highlights AAV manufacturing optimization via Lexeo’s Sf9-baculovirus processNEW YORK, May 01, 2025 (GLOBE NEWSWIRE) ...

VectorY Therapeutics (VectorY), a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced that it will have four feat ...

Abstract: The use of autonomous aerial vehicles (AAV) for collecting data from sensing devices (SDs) in areas with limited or inadequate communication infrastructure is a critical concern. In ...

Future research should focus on illuminating how different interstitial lung disease subtypes affect outcomes in AAV. Interstitial lung disease (ILD) patterns differ between patients with ...

On this episode of GEN Live, we’ll talk to experts in delivery with a focus on AAV vectors. We’ll discuss the successes the field has experienced, the challenges that remain, new technologies ...

Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor IX ...

A novel nanoneedle platform provides crucial insights by precisely quantifying AAV subpopulations—empty, partial, full, and overfilled capsids—at the molecular level, overcoming key ...

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned. According to a new modelling study, published in the journal ...

Abstract: In recent years, the application of autonomous aerial vehicle (AAV) devices in military, industrial, and civilian sectors has become increasingly widespread. Consequently, research on ...

That deal is worth $35 million per year in average annual salary, but he reportedly could have gotten an even bigger deal in AAV from the Baltimore Orioles. Roch Kubatko of MASN reported that the ...